Advances in Rheumatoid Arthritis


Rheumatoid arthritis is a relatively common inflammatory arthritis and is self-reported by 2% of the Australian population.

This module summarises the literature on contemporary understanding of adult rheumatoid arthritis (RA) focusing on current therapy, especially biological therapy.


Learning Outcomes

  1. List the eight approved biological disease-modifying antirheumatic drugs (bDMARDs), also in combination therapy with traditional DMARDs
  2. Recognise the potential of those therapeutic options with a realistic goal of remission, guiding patients in the process to lead a ‘normal life’
  3. Identify the ‘window opportunity’ that changes the long-term phenotype of the disease


Authors: Graeme Jones, Peter Nas, Stephen Hall

Article Type: Narrative review


Medical Journal of Australia
Reading: journal; textbook; book; literature review
1h : 0m
MBA: 1h : 0m
Musculoskeletal Diseases
Medical Practitioner, Medical Student, Doctor-in-Training, Non-Vocationally Registered, Nurse / Midwife, Pharmacist, Researcher, Retired, Specialist - Other, Specialist General Practitioner
You have to be logged in to see the content of this module.

Provided by

doctorportal Learning respectfully acknowledges Aboriginal and Torres Strait Islander peoples as the first inhabitants of Australia. We respect the traditional owners of lands across Australia in which our members and staff work and live, and pay respect to their elders past, present and emerging.